Atlas Trials

Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

Clinical trial NCT05327894 · RECRUITING

Trial details

NCT number
NCT05327894
Sponsor
Princess Maxima Center for Pediatric Oncology
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia
Start date
2022-12-15
Primary completion
2027-09-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.